Generic placeholder image

Current Cardiology Reviews

Editor-in-Chief

ISSN (Print): 1573-403X
ISSN (Online): 1875-6557

Perspective

Evaluation of Central Hemodynamics in the Diagnosis and Treatment of Hypertension

Author(s): Pedro Forcada and Jose F. Vilela-Martin*

Volume 19, Issue 6, 2023

Published on: 26 May, 2023

Article ID: e110523216807 Pages: 4

DOI: 10.2174/1573403X19666230511145035

[1]
Olsen MH, Angell SY, Asma S, et al. A call to action and a lifecourse strategy to address the global burden of raised blood pressure on current and future generations: The Lancet Commission on hypertension. Lancet 2016; 388(10060): 2665-712.
[http://dx.doi.org/10.1016/S0140-6736(16)31134-5] [PMID: 27671667]
[2]
Mancia G, De Backer G, Dominiczak A, et al. 2007 Guidelines for the management of arterial hypertension. J Hypertens 2007; 25(6): 1105-87.
[http://dx.doi.org/10.1097/HJH.0b013e3281fc975a] [PMID: 17563527]
[3]
Laurent S, Boutouyrie P. The structural factor of hypertension: Large and small artery alterations. Circ Res 2015; 116(6): 1007-21.
[http://dx.doi.org/10.1161/CIRCRESAHA.116.303596] [PMID: 25767286]
[4]
Chirinos JA, Segers P, Hughes T, Townsend R. Large-Artery stiffness in health and disease. J Am Coll Cardiol 2019; 74(9): 1237-63.
[http://dx.doi.org/10.1016/j.jacc.2019.07.012] [PMID: 31466622]
[5]
Nichols WW, O’Rourke MF, Vlachopoulos C. Mc Donald’s Blood Flow in ArteriesTheoretical and Clinical Principles. (6th ed.). London: CRC Press 2011; p. 768.
[6]
Williams B, Lacy PS, Thom SM, et al. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: Principal results of the Conduit Artery Function Evaluation (CAFE) study. Circulation 2006; 113(9): 1213-25.
[http://dx.doi.org/10.1161/CIRCULATIONAHA.105.595496] [PMID: 16476843]
[7]
Dahlöf B, Sever PS, Poulter NR, et al. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): A multicentre randomised controlled trial. Lancet 2005; 366(9489): 895-906.
[http://dx.doi.org/10.1016/S0140-6736(05)67185-1] [PMID: 16154016]
[8]
Cheng YB, Xia JH, Li Y, Wang JG. Antihypertensive treatment and central arterial hemodynamics: A meta-analysis of randomized controlled trials. Front Physiol 2021; 12: 762586.
[http://dx.doi.org/10.3389/fphys.2021.762586] [PMID: 34899387]
[9]
Safar ME, Siche JP, Mallion JM, London GM. Arterial mechanics predict cardiovascular risk in hypertension. J Hypertens 1997; 15(12): 1605-11.
[http://dx.doi.org/10.1097/00004872-199715120-00061] [PMID: 9488211]
[10]
Nilsson PM. Early vascular aging in hypertension. Front Cardiovasc Med 2020; 7: 6.
[http://dx.doi.org/10.3389/fcvm.2020.00006] [PMID: 32118044]
[11]
Krzesiński P, Stańczyk A, Gielerak G, Piotrowicz K. The hemodynamic patterns in hypertensive men and women of different age. J Hum Hypertens 2016; 30(3): 177-85.
[http://dx.doi.org/10.1038/jhh.2015.63] [PMID: 26134620]
[12]
Forcada P. wenty years of non-invasive vascular evaluation: From bench to bedside from theoretical to precision medicine. J Non Invasive Vasc Invest 2022; 7: 030.
[13]
Reference Values for Arterial Stiffness’ Collaboration Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors: ‘Establishing normal and reference values’. Eur Heart J 2010; 31(19): 2338-50.
[http://dx.doi.org/10.1093/eurheartj/ehq165] [PMID: 20530030]
[14]
Van Bortel LM, Laurent S, Boutouyrie P, et al. Artery Society; European society of hypertension working group on vascular structure and function; European Network for noninvasive investigation of large arteries. Expert consensus on the measurement of aortic stiffness in daily practice using Carotid Femoral Pulse Wave Velocity. J Hypertens 2012; 30(3): 445-8.
[http://dx.doi.org/10.1097/HJH.0b013e32834fa8b0] [PMID: 22278144]
[15]
Ben-Shlomo Y, Spears M, Boustred C, et al. Aortic pulse wave velocity improves cardiovascular event prediction: An individual participant meta-analysis of prospective observational data from 17,635 subjects. J Am Coll Cardiol 2014; 63(7): 636-46.
[http://dx.doi.org/10.1016/j.jacc.2013.09.063] [PMID: 24239664]
[16]
Vlachopoulos C, Xaplanteris P, Aboyans V, et al. The role of vascular biomarkers for primary and secondary prevention. A position paper from the European Society of Cardiology Working Group on peripheral circulation. Atherosclerosis 2015; 241(2): 507-32.
[http://dx.doi.org/10.1016/j.atherosclerosis.2015.05.007] [PMID: 26117398]
[17]
Townsend RR, Wilkinson IB, Schiffrin EL, et al. Recommendations for improving and standardizing vascular research on arterial stiffness. Hypertension 2015; 66(3): 698-722.
[http://dx.doi.org/10.1161/HYP.0000000000000033] [PMID: 26160955]
[18]
Vlachopoulos C, Terentes-Printzios D, Laurent S, et al. Association of estimated pulse wave velocity with survival. JAMA Netw Open 2019; 2(10): e1912831.
[http://dx.doi.org/10.1001/jamanetworkopen.2019.12831] [PMID: 31596491]
[19]
Laurent S, Chatellier G, Azizi M, et al. SPARTE Study: Normalization of arterial stiffness and cardiovascular events in patients with hypertension at medium to very high risk. Hypertension 2021; 78(4): 983-95.
[http://dx.doi.org/10.1161/HYPERTENSIONAHA.121.17579] [PMID: 34455813]
[20]
Nilsson PM, Boutouyrie P, Laurent S. Vascular Aging. Hypertension 2009; 54(1): 3-10.
[http://dx.doi.org/10.1161/HYPERTENSIONAHA.109.129114] [PMID: 19487587]
[21]
Ait-Oufella H, Collin C, Bozec E, et al. Long-term reduction in aortic stiffness: A 5.3-year follow-up in routine clinical practice. J Hypertens 2010; 28(11): 2336-41.
[http://dx.doi.org/10.1097/HJH.0b013e32833da2b2] [PMID: 20683338]
[22]
Zieman SJ, Melenovsky V, Kass DA. Mechanisms, pathophysiology, and therapy of arterial stiffness. Arterioscler Thromb Vasc Biol 2005; 25(5): 932-43.
[http://dx.doi.org/10.1161/01.ATV.0000160548.78317.29] [PMID: 15731494]
[23]
Asmar R, O’Rourke MF, Safar M. Arterial Stiffness and Pulse Wave VelocityClinical Applications. France: Elsevier SAS 1999.
[24]
Laurent S, Briet M, Boutouyrie P. Arterial stiffness as surrogate end point: Needed clinical trials. Hypertension 2012; 60(2): 518-22.
[http://dx.doi.org/10.1161/HYPERTENSIONAHA.112.194456] [PMID: 22733473]
[25]
Sharman JE, Marwick TH, Gilroy D, Otahal P, Abhayaratna WP, Stowasser M. Randomized trial of guiding hypertension management using central aortic blood pressure compared with best-practice care: Principal findings of the BP GUIDE study. Hypertension 2013; 62(6): 1138-45.
[http://dx.doi.org/10.1161/HYPERTENSIONAHA.113.02001] [PMID: 24060891]
[26]
Weber T, Protogerou AD, Agharazii M, et al. Twenty-Four–Hour Central (Aortic) systolic blood pressure: Reference values and dipping patterns in untreated individuals. Hypertension 2022; 79(1): 251-60.
[http://dx.doi.org/10.1161/HYPERTENSIONAHA.121.17765] [PMID: 34775789]
[27]
Vilela-Martin JF, Forcada PJ. Editorial: The importance of the central hemodynamic in the cardiovascular diseases development. Front Cardiovasc Med 2022; 9: 1036440.
[http://dx.doi.org/10.3389/fcvm.2022.1036440] [PMID: 36299871]
[28]
Nowak KL, Rossman MJ, Chonchol M, Seals DR. Strategies for achieving healthy vascular aging. Hypertension 2018; 71(3): 389-402.
[http://dx.doi.org/10.1161/HYPERTENSIONAHA.117.10439] [PMID: 29311256]
[29]
Laurent S, Boutouyrie P, Cunha PG, Lacolley P, Nilsson PM. Concept of extremes in vascular aging. Hypertension 2019; 74(2): 218-28.
[http://dx.doi.org/10.1161/HYPERTENSIONAHA.119.12655] [PMID: 312037]

© 2024 Bentham Science Publishers | Privacy Policy